Brief: Inozyme Pharma Announces Partnership With Rady Children's Institute For Genomic Medicine To Advance Newborn Screening For Genetic Diseases
16/06/2022 12:35
June 16 (Reuters) - Inozyme Pharma Inc INZY.O :
* INOZYME PHARMA ANNOUNCES PARTNERSHIP WITH RADY CHILDREN’S
INSTITUTE FOR GENOMIC MEDICINE TO ADVANCE NEWBORN SCREENING FOR
GENETIC DISEASES
Source text for Eikon: ID:nGNXLn08C
Further company coverage: INZY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inozyme Pharma
See all newsBrief: Inozyme Pharma postpones 2025 annual meeting of stockholders
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin